Clinical Trial Information

Memgen has already completed a Phase I clinical trial of its ISF35 technology at M.D. Anderson Cancer Center in Houston, Texas, and is nearing completion of another Phase I trial at Moores Cancer Center at the University of California, San Diego (UCSD). An additional trial at UCSD is now in progress and is actively recruiting patients.

Other clinical trials are planned and will be initiated in the near future.

Phase Ib Infusion + FCR Trial (in progress, actively recruiting)

For details please see Phase Ib Infusion + FCR Trial.

Phase I Intranodal Trial (complete, ongoing follow-up)

For details please see Phase I Intranodal Trial.

Phase I Infusion Trial (complete)

For details please see Phase I Infusion Trial.